APA (7th ed.) Citation

Forsyth, S., Yip, K., Foran, B., Gougis, P., Wheeler, G., White, L., . . . Forster, M. (2020). 979TiP POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck. Annals of Oncology, 31, S686. https://doi.org/10.1016/j.annonc.2020.08.1094

Chicago Style (17th ed.) Citation

Forsyth, S., et al. "979TiP POPPY: A Phase II Trial to Assess the Efficacy and Safety Profile of Pembrolizumab in Patients with Performance Status 2 with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck." Annals of Oncology 31 (2020): S686. https://doi.org/10.1016/j.annonc.2020.08.1094.

MLA (9th ed.) Citation

Forsyth, S., et al. "979TiP POPPY: A Phase II Trial to Assess the Efficacy and Safety Profile of Pembrolizumab in Patients with Performance Status 2 with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck." Annals of Oncology, vol. 31, 2020, p. S686, https://doi.org/10.1016/j.annonc.2020.08.1094.